WIPO logo
모바일 | Deutsch | English | Español | Français | 日本語 | Português | Русский | 中文 | العربية |
PATENTSCOPE

국제 및 국내 특허문헌 검색
World Intellectual Property Organization
검색
 
열람
 
번역
 
옵션
 
뉴스
 
로그인
 
도움말
 
기계 번역
1. (WO2012050229) RECOMBINANT VACCINIA VIRUS HAVING HEMAGGLUTININ PROTEIN GENES DERIVED FROM NOVEL INFLUENZA VIRUSES
국제사무국에 기록된 최신 서지정보   

공개번호:    WO/2012/050229    국제출원번호:    PCT/JP2011/074086
공개일: 19.04.2012 국제출원일: 13.10.2011
국제예비심사 청구일:    14.08.2012    
IPC:
C12N 15/09 (2006.01), A61K 31/711 (2006.01), A61K 35/76 (2006.01), A61K 39/145 (2006.01), A61K 48/00 (2006.01), A61P 31/16 (2006.01), C12N 7/04 (2006.01)
출원인: TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE [JP/JP]; 2-1-6, Kamikitazawa, Setagaya-ku, Tokyo 1568506 (JP) (For All Designated States Except US).
THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE [JP/JP]; 1-6-1 Okubo, Kita-ku, Kumamoto-shi, Kumamoto 8608568 (JP) (For All Designated States Except US).
NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY [JP/JP]; Kita 8-jyo Nishi 5-chome, Kita-ku, Sapporo-shi, Hokkaido 0600808 (JP) (For All Designated States Except US).
KOHARA, Michinori [JP/JP]; (JP) (For US Only).
YASUI, Fumihiko [JP/JP]; (JP) (For US Only).
MURAKAMI, Toshio [JP/JP]; (JP) (For US Only).
KIDA, Hiroshi; (For US Only).
SAKODA, Yoshihiro; (For US Only)
발명자: KOHARA, Michinori; (JP).
YASUI, Fumihiko; (JP).
MURAKAMI, Toshio; (JP).
KIDA, Hiroshi; .
SAKODA, Yoshihiro;
대리인: KOBAYASHI, Hiroshi; ABE, IKUBO & KATAYAMA, Fukuoka Bldg. 9th Fl., 8-7, Yaesu 2-chome, Chuo-ku, Tokyo 1040028 (JP)
우선권 정보:
2010-233064 15.10.2010 JP
발명의 명칭: (EN) RECOMBINANT VACCINIA VIRUS HAVING HEMAGGLUTININ PROTEIN GENES DERIVED FROM NOVEL INFLUENZA VIRUSES
(FR) VIRUS RECOMBINANT DE LA VACCINE AYANT UN GÈNE DE PROTÉINE D'HÉMAGGLUTININE DÉRIVÉE D'UN NOUVEAU TYPE DE VIRUS DE LA GRIPPE
(JA) 新型インフルエンザウイルス由来ヘマグルチニンタンパク質遺伝子を有する組換えワクシニアウイルス
요약서: front page image
(EN)Provided are a highly-safe recombinant vaccinia virus that is effective in preventing the onset of symptoms due to infection by novel influenza viruses, and a vaccine for the novel influenza viruses containing the recombinant vaccinia virus. This recombinant vaccinia virus is capable of expressing the hemagglutinin protein genes of the novel influenza viruses. This novel influenza vaccine contains the recombinant vaccinia virus.
(FR)L'invention concerne un virus recombinant de la vaccine présentant une efficacité inhibant la sidération due à une infection par un nouveau type de virus de la grippe, et un vaccin contre ce nouveau type de virus de la grippe contenant ledit virus recombinant de la vaccine. Le virus recombinant de la vaccine sur lequel porte l'invention permet d'exprimer un gène de protéine d'hémagglutinine du nouveau type de virus de la grippe. Un vaccin contre le nouveau type de virus de la grippe sur lequel porte également l'invention, contient le virus recombinant de la vaccine susmentionné.
(JA) 新型インフルエンザウイルス感染による発症の防止に有効性があり安全性の高い組換えワクシニアウイルス、及びこれを含む新型インフルエンザウイルス用ワクチンを提供する。本発明にかかる組換えワクシニアウイルスは、新型インフルエンザウイルスのヘマグルチニンタンパク質遺伝子を発現することができる。本発明にかかる新型インフルエンザウイルスワクチンは、当該組換えワクシニアウイルスを含むものである。
지정국: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
공개언어: Japanese (JA)
출원언어: Japanese (JA)